Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of the American College of Cardiology

• Publication date

  2006-01-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JACC.2005.06.085PMID 16386664
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic Dysfunction

  2007cited by this paper
• Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

  2004cited by this paper
• Use of NT‐proBNP in routine testing and comparison to BNP

  2004cited by this paper
• Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease.

  2004cited by this paper
• N-Terminal Pro–B-Type Natriuretic Peptide Levels for Dynamic Risk Stratification of Patients With Acute Coronary Syndromes

  2004cited by this paper
• Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

  2004cited by this paper
• Plasma natriuretic peptide levels and the risk of cardiovascular events and death

  2004cited by this paper
• Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

  2004cited by this paper
• Plasma Brain Natriuretic Peptide to Detect Preclinical Ventricular Systolic or Diastolic Dysfunction: A Community-Based Study

  2004cited by this paper
• Biochemical indicators of cardiac and renal function in a healthy elderly population.

  2004cited by this paper
• Application of NT‐proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure

  2004cited by this paper
• N‐Terminal Pro‐Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)‐IV Substudy

  2003cited by this paper
• B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction

  2003cited by this paper
• Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

  2003cited by this paper
• B-type natriuretic peptides: a diagnostic breakthrough for clinicians.

  2003cited by this paper
• B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study.

  2003cited by this paper
• Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath.

  2003influential reference
• The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes☆

  2002cited by this paper
• Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

  2002cited by this paper
• Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.

  2002cited by this paper
• Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations

  2002cited by this paper
• N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation.

  2002cited by this paper
• Plasma brain natriuretic peptide concentration: impact of age and gender.

  2002cited by this paper
• Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction.

  2001cited by this paper
• A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

  2001cited by this paper
• Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group.

  2001cited by this paper
• The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

  2001cited by this paper
• Treatment of heart failure guided by plasma amino-terminal brain natriuretic peptide (N-BNP) levels improves outcome

  2000cited by this paper
• Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.

  2000cited by this paper
• Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy.

  1999cited by this paper
• Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group.

  1999influential reference
• Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.

  1998cited by this paper
• Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment

  1997cited by this paper
• Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.

  1997cited by this paper
• Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.

  1997cited by this paper
• Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.

  1997cited by this paper
• Brain natriuretic peptide predicts mortality in the elderly.

  1997cited by this paper
• Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease

  1997cited by this paper
• Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.

  1996cited by this paper
• The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma.

  1995cited by this paper
• Plasma brain natriuretic peptide in assessment of acute dyspnoea.

  1994cited by this paper
• Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure.

  1993cited by this paper
• A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

  1983cited by this paper
• Ejection fraction image: a noninvasive index of regional left ventricular wall motion.

  1978cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper

• Urinary NT-proBNP compared head-to-head to plasmatic NT-proBNP in a real life collective with an ICD

  2024cites this paper
• Prognostic value of N-terminal Pro–B-Type natriuretic peptide in patients with intermediate coronary lesions

  2022cites this paper
• Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease

  2021cites this paper
• Salt intake causes B-type natriuretic peptide elevation independently of blood pressure elevation in the general population without hypertension and heart disease

  2021cites this paper
• Role of resistin, IL-6 and NH2-terminal portion proBNP in the pathogenesis of cardiac disease in type 2 diabetes mellitus

  2020cites this paper
• Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction

  2020cites this paper
• Estimation of B-type Natriuretic Peptide Values from N-Terminal proBNP Levels.

  2020cites this paper
• Parameters of tissue iron overload and cardiac function in patients with thalassemia major and intermedia

  2020cites this paper
• Update on current practice in laboratory medicine in respect of natriuretic peptide testing for heart failure diagnosis and management in Europe. The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study.

  2020cites this paper
• Determinants of Cardiorespiratory Fitness in Patients with Heart Failure Across a Wide Range of Ejection Fractions.

  2019cites this paper
• The impact of renal function on the prognostic value of N-terminal pro–B-type natriuretic peptide in patients with coronary artery disease

  2019cites this paper
• B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease

  2019cites this paper
• NT‐proBNP is associated with mortality and adverse cardiac events in patients with atrial fibrillation presenting to the emergency department

  2018cites this paper
• Sleep study–guided multidisciplinary therapy (SGMT) for patients with acute coronary syndrome: Trial rationale and design

  2018cites this paper
• N-Terminal B-type Natriuretic Peptide in Heart Failure.

  2018cites this paper
• The Confounding Effects of Non-cardiac Pathologies on the Interpretation of Cardiac Biomarkers

  2018cites this paper
• Biomarkers and heart–kidney interaction

  2018cites this paper
• 10-1-2014 B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk : the CHARGE-AF Consortium of community-based cohort studies

  2017cites this paper
• Pre-procedural peripheral endothelial function is associated with increased serum creatinine following percutaneous coronary procedure in stable patients with a preserved estimated glomerular filtration rate.

  2017cites this paper
• Cardiac Natriuretic Peptides

  2017cites this paper
• Are Heart Failure Management Recommendations and Guidelines Followed in Laboratory Medicine in Europe and North America? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) Study.

  2017cites this paper
• Novel Biomarkers of Subclinical Cardiac Dysfunction in the General Population

  2017cites this paper
• N-terminal pro B type natriuretic peptide in high cardiovascular-risk patients for noncardiac surgery: What is the current prognostic evidence?

  2016cites this paper
• Usefulness of NT-proBNP in the Follow-Up of Patients after Myocardial Infarction

  2016cites this paper
• Plasma B-type natriuretic peptide concentration is independently associated with kidney function decline in Japanese patients with chronic kidney disease

  2016cites this paper
• Prognostic Significance of Serum Uric Acid Levels in Congestive Cardiac Failure and Its Correlation with Ejection Fraction

  2016cites this paper
• Acute Myocardial Infarction Plasma Concentrations of Myeloperoxidase Predict Mortality After Myocardial Infarction

  2016cites this paper
• A novel troponin T peptide in humans: Assay, biochemistry and preliminary findings in acute coronary syndromes.

  2015cites this paper
• Clinical Use of Serum Biomarkers in the Prediction of Cardiovascular Risk

  2015cites this paper
• Role of Soluble ST2 as a Prognostic Marker in Patients with Acute Heart Failure and Renal Insufficiency

  2015cites this paper
• Urinary NT-proBNP is Independently Associated with Long-term Prognosis of Mortality in Chronic Heart Failure

  2015cites this paper
• [Effect of 12-Months Therapy With Perindopril A on Structural-Functional State of the Microcirculatory Vascular Bed in Patients With Chronic Heart Failure].

  2015cites this paper
• administration in healthy men Plasma NT-proBNP increases in response to LPS

  2015cites this paper
• Serial Measurements of N-Terminal Pro-Brain Natriuretic Peptide in Patients with Coronary Heart Disease

  2015cites this paper
• CNP Signal Peptide in Patients with Cardiovascular Disease

  2015cites this paper
• Racial Differences in Circulating Natriuretic Peptide Levels: The Atherosclerosis Risk in Communities Study

  2015cites this paper
• Biomarkers in Acute Heart Failure - Cardiac And Kidney.

  2015cites this paper
• NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism

  2014cites this paper
• Myeloperoxidase-derived oxidants: their Intracellular targets, defence mechanisms and role in disease

  2014cites this paper
• B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.

  2014cites this paper
• La selezione dell’esame: il caso del BNP

  2014cites this paper
• Association of high serum pro-BNP levels with severity of coronary artery disease and its limitations

  2014cites this paper
• B‐type Natriuretic Peptides for the Prediction of Cardiovascular Events in Patients With Stable Coronary Heart Disease: The Heart and Soul Study

  2014cites this paper
• Características epidemiológicas, clínicas, tratamiento y pronóstico de los pacientes con diagnóstico de síndrome coronario agudo en unidad especializada Epidemiological and clinical characteristics, treatment and prognosis of patients with acute coronary syndrome in a specialized unit

  2014cites this paper
• Association of N‐terminal pro‐brain natriuretic peptide with the severity of coronary artery disease in patients with normal left ventricular ejection fraction

  2014cites this paper
• Cardiovascular Biomarker Assessment Across Glycemic Status

  2014cites this paper
• The selection of the test: the case of BNP

  2014cites this paper
• The ability of NT-proBNP to detect chronic heart failure and predict all-cause mortality is higher in elderly Chinese coronary artery disease patients with chronic kidney disease

  2013cites this paper
• Correlation of NT-proBNP levels and cardiac iron concentration in patients with transfusion-dependent thalassemia major.

  2013cites this paper
• Serum Probnp Associated with the Severity of Coronary Artery Disease: its Limitation in Metabolic Syndrome

  2013cites this paper
• Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.

  2013cites this paper
• The effect of cardiac rehabilitation exercise training on left ventricular remodelling in patients with recent myocardial infarction

  2013cites this paper
• Kidney function and congestive heart failure. The Norwegian perspective.

  2013cites this paper
• N-terminal prohormone B-type natriuretic peptide and cardiovascular risk in stable coronary artery disease: a meta-analysis of nine prospective studies.

  2013cites this paper
• Translational phases of evidence in a prognostic biomarker: a systematic review and meta-analysis of natriuretic peptides and the prognosis of stable coronary disease

  2012cites this paper
• The occurance of genetic variations in the MYH9 gene and their association with CKD in a mixed South African population

  2012cites this paper
• Biomarkers.

  2012cites this paper
• Equal performance of novel N-terminal proBNP (Cardiac proBNP®) and established BNP (Triage BNP®) point-of-care tests.

  2012cites this paper
• Brain Natriuretic Peptide Is Associated with Worsening and Mortality in Acute Stroke Patients but Adds No Prognostic Value to Clinical Predictors of Outcome

  2012cites this paper
• Impact of the Look AHEAD Intervention on NT‐pro Brain Natriuretic Peptide in Overweight and Obese Adults With Diabetes

  2012cites this paper
• Marcadores cardiacos en diferentes grados de enfermedad renal crónica, influencia de la inflamación y de la afectación cardiaca previa

  2012cites this paper
• Can atrial natriuretic peptides measurement diagnose heart failure at different age groups?

  2012cites this paper
• [Cardiac markers in different degrees of chronic kidney disease: influence of inflammation and previous heart disease].

  2012cites this paper
• Péptido natriurético cerebral y su pro-hormona como predictor de riesgo cardiovascular en cirugía no cardiaca

  2012cites this paper
• Prognostic utility of B-type natriuretic peptides in patients with heart failure and renal dysfunction

  2012cites this paper
• Koroner kollateral dolaşım ve plazma N-terminal pro-B-tipi natriüretik peptit düzeyleri arasındaki ilişki Relationship between coronary collateral circulation and plasma levels of N-terminal pro-B-type natriuretic peptide

  2011cites this paper
• NT-proBNP: a marker of preclinical cardiac damage in arterial hypertension.

  2011cites this paper
• Understanding cardiac biomarkers in end‐stage kidney disease: Frequently asked questions and the promise of clinical application

  2011cites this paper
• Prognostic value of B-type natriuretic peptide for assessment of left ventricular function in patients with chronic kidney disease.

  2011cites this paper
• The Predictive Value of Preoperative Natriuretic Peptide Concentrations in Adults Undergoing Surgery: A Systematic Review and Meta-Analysis

  2011cites this paper
• Exercise-induced changes of B-type natriuretic peptide uncover the unknown coronary artery disease in patients with chest pain and normal left ventricular systolic function

  2011cites this paper
• [Relationship between coronary collateral circulation and plasma levels of N-terminal pro-B-type natriuretic peptide].

  2011cites this paper
• Роль мозгового натрийуретического пептида и его N-концевого предшественника в диагностике хронической сердечной недостаточности и бессимптомной дисфункции левого желудочка при сахарном диабете 2 типа

  2011cites this paper
• vascular surgery: risk stratification, novel cardiac biomarkers, and their importance in abdominal aortic aneurysm surgery.

  2011cites this paper
• Relationship between serum N-terminal Pro Brain Natriuretic Peptide (NT-Pro BNP) level and the severity of coronary artery involvements

  2011cites this paper
• CAN ATRIAL NATRIURETIC PEPTIDES MEASUREMENT DIAGNOSE HEART FAILURE AT DIFFERENT AGE GROUPS? (LETTER TO EDITOR)

  2011cites this paper
• Use of B‐type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease

  2011cites this paper
• Preoperative cardiac risk assessment in vascular surgery: risk stratification, novel cardiac biomarkers, and their importance in abdominal aortic aneurysm surgery

  2011cites this paper
• High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial

  2011cites this paper
• Postoperative increase in B-type natriuretic peptide levels predicts adverse outcome after cardiac surgery.

  2011cites this paper
• Increased B-type natriuretic peptide and decreased proteinuria might reflect decreased capillary leakage and is associated with a better outcome in patients with severe burns

  2011cites this paper
• Improvement of the cardiac marker N-terminal-pro brain natriuretic peptide through adjustment for renal function: a stratified multicenter trial

  2010cites this paper
• Depressive symptoms affect the relationship of N-terminal pro B-type natriuretic peptide to cardiac event-free survival in patients with heart failure.

  2010cites this paper
• Significance of B-type natriuretic peptide measurement in patients with chronic kidney disease.

  2010cites this paper
• N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.

  2010cites this paper
• Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.

  2010cites this paper
• N‐terminal pro‐brain natriuretic peptide from fresh urine for the biochemical detection of heart failure and left ventricular dysfunction

  2010cites this paper
• B-type natriuretic peptide in outpatients after myocardial infarction: optimized cut-off value for incident heart failure prediction.

  2010cites this paper
• Prediction of long-term outcome after primary percutaneous coronary intervention for acute anterior myocardial infarction.

  2010cites this paper
• Direct comparison of B-type natriuretic peptide and N-terminal pro-BNP for assessment of cardiac function in a large population of symptomatic patients.

  2010cites this paper
• The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model.

  2010cites this paper
• Evaluation of patients with suspected coronary artery disease.

  2010cites this paper
• Natriuretic peptides: the feline experience.

  2010cites this paper
• Prognostic value of cardiac troponins and natriuretic peptides in hospitalized nursing home residents.

  2010cites this paper
• Повышенный уровень натрийуретического пептида B-типа (NT-proBNP) как фактор риска у кардиохирургических больных

  2010cites this paper
• Evaluation of pulse wave analysis to assess coronary artery disease

  2010cites this paper
• N-Terminal Pro–B-Type Natriuretic Peptide–Guided, Intensive Patient Management in Addition to Multidisciplinary Care in Chronic Heart Failure

  2010cites this paper
• Avaliação dos níveis plasmáticos de peptídeo natriurético tipo B e relação com obesidade mórbida e comorbidades associadas

  2010cites this paper
• Prognostic value of B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure.

  2009cites this paper
• Does renal clearance differ between the B-type natriuretic peptides (BNP versus NT-proBNP)?

  2009cites this paper